Premier Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,350
Closed -$803K 16
2022
Q4
$803K Sell
17,350
-25,415
-59% -$1.1M 1.01% 29
2022
Q3
$1.66M Sell
42,765
-13,040
-23% -$523K 1.72% 20
2022
Q2
$2.29M Sell
55,805
-79,910
-59% -$3.25M 1.85% 26
2022
Q1
$6.01M Sell
135,715
-67,830
-33% -$2.94M 1.87% 26
2021
Q4
$8.65M Buy
+203,545
New +$8.55M 1.5% 27

Other funds holding BSX

Premier Asset Management's BSX Position: Q1 2023 in Review

Premier Asset Management sold out of Boston Scientific (BSX) in Q1 2023, closing a stake of 17,350 shares — an estimated $803K sold.

Premier Asset Management first reported a position in BSX in Q4 2021 and held it in 5 quarters. The position peaked at $8.65M in Q4 2021. 996 funds tracked by Wall St. Rank hold BSX as of Q1 2023.

  • Premier Asset Management reported no remaining Boston Scientific position as of Q1 2023 after selling out during the quarter.
  • Premier Asset Management sold 17,350 Boston Scientific shares in Q1 2023, an estimated $803K.
  • Premier Asset Management first reported a position in Boston Scientific in Q4 2021 and held it in 5 quarters.
  • Premier Asset Management's Boston Scientific position peaked at $8.65M in Q4 2021.
  • 996 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2023.

Based on Premier Asset Management's 13F filing for Q1 2023.